Australian cannabis company Cronos (ASX: CAU) will be set to start stacking Asian shelves with a pure cannabidiol (CBD) heat and cooling gel for elite athletes to help with recovery. The gels for Australian’s, however, may take some time.
So far, there has not been much in the way of merger & acquisition (MA) within the Australia cannabis industry. With more cannabis companies emerging within Australia, this could soon be about to change.
Taking advantage of the huge, and ever-growing cannabis medical market, CSIRO is looking to partner with local manufacturers to produce medical cannabis products, such as tablets and cough lollies.
Bod Australia (ASX: BDA) have partnered with H&H and have now released numerous medicinal hemp and cannabis products across global the market. This article looks at some of their products and the growing positive outlook.
Despite challenges throughout COVID-19, such as fast moving regulatory change, varying public-health rules and the general worry for the economy, cannabis retailers say the pandemic has had some positive benefits.
Western-Australian based cannabis company Little Green Pharma (LGP) has been announced to be the primary supplier of cannabis oils for a national trial for medicinal cannabis in France.
A 10-year deal reached between the Australian Natural Therapeutics Group (ANTG) and the EU could mean that Australia is set to be a leader in the medical cannabis industry, after a major shipment to the European Union.
Hemp Farms Australia, one of the country’s largest suppliers of industrial hemp, says that general views around the plant are slowly changing. With its health and medical benefits coming to light, the industry is gradually changing.
Since the start of the COVID-19 pandemic, the market for cannabis-infused products has slowed. But with light at the end of the tunnel, this could be a great time for more cannabis companies to enter the market.
Australian Primary Hemp company has sealed a deal with the supermarket chain Woolworths, which will now be stocking hemp-based baking products in its stores, such as hemp protein bars. CEO Neale Joseph is “really pleased about it’.
Tasmanian Alkaloids’ have opened up a new medicinal cannabis facility in the central-north region of Tasmania. It will cultivate, extract, and create medical cannabis medications, with up to 90 tonnes each year.
As the use of medicinal cannabis is growing, not only in Australia, but worldwide, this article lists the top 20 cannabis companies within Australia, and notes what their market capitalisation is estimated at.
According to new research by Prohibition Partners, the growing legalisation in Australia is likely to lead the market to being the largest legal cannabis market in the Oceania area. Figures are expected to reach $1.5 billion by 2025.
The medicinal cannabis industry in South Australia could be set to take off with a new manufacturing facility for medicinal cannabis being planned to create 1000 jobs in Adelaide.
Cannatrek, an Australian medicinal cannabis company, has plans to develop a $160 million plantation near Shepparton, VIC. It is predicted to produce 160 tonnes of medicinal cannabis each year in Victoria.
Investment strategist Mark Bernberg says Australia is throwing away billions of dollars of possible tax revenue from cannabis being legalised, and questions why it is not being tackled on the election campaign.
